Form 8-K - Current report:
SEC Accession No. 0001104659-26-041981
Filing Date
2026-04-10
Accepted
2026-04-10 16:05:47
Documents
12
Period of Report
2026-04-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2611526d1_8k.htm   iXBRL 8-K 25628
5 GRAPHIC tm2611526d1_8kimg001.jpg GRAPHIC 27163
  Complete submission text file 0001104659-26-041981.txt   261802

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cyph-20260407.xsd EX-101.SCH 3008
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyph-20260407_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyph-20260407_pre.xml EX-101.PRE 22354
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2611526d1_8k_htm.xml XML 3219
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
CYPHERPUNK TECHNOLOGIES INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 26854866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)